Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
PaperCitations, authors & open-access status
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 2,292 citations, 2010 year and closed oa status.
2,292
Citations
2010
Year
closed
OA Status